Related Experiment Video
Updated: Jun 17, 2026
09:13
Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
Published on: November 22, 2024
Chk2 splice variants express a dominant-negative effect on the wild-type Chk2 kinase activity
Elisabet Ognedal Berge1, Vidar Staalesen, Anne Hege Straume
1Department of Molecular Biology, University of Bergen, N-5020 Bergen, Norway; Section of Oncology, Institute of Medicine, University of Bergen, N-5021 Bergen, Norway.
Biochimica Et Biophysica Acta
|January 19, 2010
Summary
Pathological splicing creates Chk2 variants that impair wild-type Chk2 function in breast cancer. These splice variants repress Chk2 activity through heterodimerization, independent of their own kinase activity.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Pathological splicing is prevalent in cancer, affecting gene function.
- Chk2 (serine/threonine kinase) is crucial for DNA damage response and cell cycle control.
- The functional impact of Chk2 splice variants in cancer remains largely unknown.
Purpose of the Study:
- To investigate the function of four Chk2 splice variants identified in human breast carcinomas.
- To determine if these variants affect wild-type Chk2 activity.
Main Methods:
- Stable expression of four Chk2 splice variants as nuclear proteins.
- Assessment of kinase activity of splice variants.
- Evaluation of the impact of splice variants on wild-type Chk2 activity via heterodimerization.
Main Results:
- Two variants (Chk2Delta4, Chk2del(2-3)) retained kinase activity; two (Chk2Delta11, Chk2isoI) were kinase-inactive.
- All four Chk2 splice variants inhibited wild-type Chk2 activity.
- Inhibition occurred through heterodimerization, irrespective of the variant's intrinsic kinase activity.
Conclusions:
- Alternative splicing of Chk2 represents a novel mechanism for repressing its wild-type function in cancer.
- Chk2 splice variants can act as dominant-negative regulators of Chk2 signaling.
- Understanding these variants is critical for cancer therapy development.
Related Concept Videos
01:32RNA Splicing
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...